These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1385213)

  • 1. Altered protein folding may be the molecular basis of most cases of cystic fibrosis.
    Thomas PJ; Ko YH; Pedersen PL
    FEBS Lett; 1992 Nov; 312(1):7-9. PubMed ID: 1385213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemical chaperones correct the mutant phenotype of the delta F508 cystic fibrosis transmembrane conductance regulator protein.
    Brown CR; Hong-Brown LQ; Biwersi J; Verkman AS; Welch WJ
    Cell Stress Chaperones; 1996 Jun; 1(2):117-25. PubMed ID: 9222597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysfunction of CFTR bearing the delta F508 mutation.
    Welsh MJ; Denning GM; Ostedgaard LS; Anderson MP
    J Cell Sci Suppl; 1993; 17():235-9. PubMed ID: 7511616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cystic fibrosis mutation (delta F508) does not influence the chloride channel activity of CFTR.
    Li C; Ramjeesingh M; Reyes E; Jensen T; Chang X; Rommens JM; Bear CE
    Nat Genet; 1993 Apr; 3(4):311-6. PubMed ID: 7526932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cystic fibrosis: a disease of altered protein folding.
    Qu BH; Strickland E; Thomas PJ
    J Bioenerg Biomembr; 1997 Oct; 29(5):483-90. PubMed ID: 9511933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A delta F508 mutation in mouse cystic fibrosis transmembrane conductance regulator results in a temperature-sensitive processing defect in vivo.
    French PJ; van Doorninck JH; Peters RH; Verbeek E; Ameen NA; Marino CR; de Jonge HR; Bijman J; Scholte BJ
    J Clin Invest; 1996 Sep; 98(6):1304-12. PubMed ID: 8823295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered chloride ion channel kinetics associated with the delta F508 cystic fibrosis mutation.
    Dalemans W; Barbry P; Champigny G; Jallat S; Dott K; Dreyer D; Crystal RG; Pavirani A; Lecocq JP; Lazdunski M
    Nature; 1991 Dec 19-26; 354(6354):526-8. PubMed ID: 1722027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel natural product compound enhances cAMP-regulated chloride conductance of cells expressing CFTR[delta]F508.
    deCarvalho AC; Ndi CP; Tsopmo A; Tane P; Ayafor J; Connolly JD; Teem JL
    Mol Med; 2002 Feb; 8(2):75-87. PubMed ID: 12080183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the delta F508 mutation on the structure, function, and folding of the first nucleotide-binding domain of CFTR.
    Thomas PJ; Pedersen PL
    J Bioenerg Biomembr; 1993 Feb; 25(1):11-9. PubMed ID: 7680027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive.
    Denning GM; Anderson MP; Amara JF; Marshall J; Smith AE; Welsh MJ
    Nature; 1992 Aug; 358(6389):761-4. PubMed ID: 1380673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cystic fibrosis transmembrane conductance regulator mutations that disrupt nucleotide binding.
    Logan J; Hiestand D; Daram P; Huang Z; Muccio DD; Hartman J; Haley B; Cook WJ; Sorscher EJ
    J Clin Invest; 1994 Jul; 94(1):228-36. PubMed ID: 7518829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Turnover of the cystic fibrosis transmembrane conductance regulator (CFTR): slow degradation of wild-type and delta F508 CFTR in surface membrane preparations of immortalized airway epithelial cells.
    Wei X; Eisman R; Xu J; Harsch AD; Mulberg AE; Bevins CL; Glick MC; Scanlin TF
    J Cell Physiol; 1996 Aug; 168(2):373-84. PubMed ID: 8707873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterologous expression of delta F508 CFTR results in decreased sialylation of membrane glycoconjugates.
    Dosanjh A; Lencer W; Brown D; Ausiello DA; Stow JL
    Am J Physiol; 1994 Feb; 266(2 Pt 1):C360-6. PubMed ID: 7511336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation and characterization of a delta F508 cystic fibrosis mouse model.
    Colledge WH; Abella BS; Southern KW; Ratcliff R; Jiang C; Cheng SH; MacVinish LJ; Anderson JR; Cuthbert AW; Evans MJ
    Nat Genet; 1995 Aug; 10(4):445-52. PubMed ID: 7545494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies for correcting the delta F508 CFTR protein-folding defect.
    Brown CR; Hong-Brown LQ; Welch WJ
    J Bioenerg Biomembr; 1997 Oct; 29(5):491-502. PubMed ID: 9511934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro pharmacologic restoration of CFTR-mediated chloride transport with sodium 4-phenylbutyrate in cystic fibrosis epithelial cells containing delta F508-CFTR.
    Rubenstein RC; Egan ME; Zeitlin PL
    J Clin Invest; 1997 Nov; 100(10):2457-65. PubMed ID: 9366560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The cystic fibrosis gene: mutation and the function of CFTR protein].
    Goossens M
    Ann Pediatr (Paris); 1991 Nov; 38(9):591-4. PubMed ID: 1721508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The common variant of cystic fibrosis transmembrane conductance regulator is recognized by hsp70 and degraded in a pre-Golgi nonlysosomal compartment.
    Yang Y; Janich S; Cohn JA; Wilson JM
    Proc Natl Acad Sci U S A; 1993 Oct; 90(20):9480-4. PubMed ID: 7692448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracellular turnover of cystic fibrosis transmembrane conductance regulator. Inefficient processing and rapid degradation of wild-type and mutant proteins.
    Ward CL; Kopito RR
    J Biol Chem; 1994 Oct; 269(41):25710-8. PubMed ID: 7523390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultrastructural localization of variant forms of cystic fibrosis transmembrane conductance regulator in human bronchial epithelial of xenografts.
    Yang Y; Engelhardt JF; Wilson JM
    Am J Respir Cell Mol Biol; 1994 Jul; 11(1):7-15. PubMed ID: 7517144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.